Carlos Baleba has passed his medical examination with Manchester United and is expected to join the club from Brighton & Hove Albion [1, 3].
The signing marks a significant investment in the club's midfield and suggests that Manchester United has completed its squad reinforcements for the current summer window.
Reports indicate the transfer fee for the midfielder is £70 million [3]. The club may make an official announcement regarding the arrival on Monday [3]. This move follows a period of pursuit as the club sought to bolster its central options before the deadline.
Sky Sports analyst Danyal Khan said it is unlikely Manchester United will add to their summer business after the medical was completed [1]. The acquisition of Baleba appears to be the final piece of the club's strategic recruitment plan for the season.
United have been closing in on the Brighton player for some time [4]. The medical process was completed during the week leading up to the expected announcement [3].
By securing Baleba, the club has addressed a primary target in the midfield. The transition from Brighton to Manchester signifies a major step for the player and a calculated expenditure for the club's leadership [1, 2].
While other targets were rumored earlier in the window, the focus has shifted entirely to finalizing the Baleba deal [3]. The club now turns its attention to integrating the new signing into the squad for upcoming fixtures.
“Baleba has reportedly passed his Manchester United medical”
The acquisition of Carlos Baleba for a reported £70 million indicates that Manchester United is prioritizing defensive stability and youth in the midfield. By signaling that this is likely the final signing of the summer, the club is moving from a recruitment phase to a stabilization phase, focusing on squad cohesion rather than further market activity.
